AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.
AC BioScience has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
AC BioScience is headquartered in Ecublens, Switzerland.
AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.
AC BioScience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AC BioScience — Funding & Investors." VCBacked, August 26, 2022, https://www.vcbacked.co/company/ac-bioscience. Accessed August 13, 2026.
VCBacked. (2022). AC BioScience — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ac-bioscience
{{cite web |title=AC BioScience — Funding & Investors |url=https://www.vcbacked.co/company/ac-bioscience |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated